JB PHARMA Q1 PERFROMANCE

  • jb pharma records 12 per cent revenue growth in q1

    JB Pharma records 12 per cent revenue growth in Q1

    Operating earnings before interest depreciation and taxes (EBITDA) improved by 20 per cent to Rs 292 crore in Q1 FY25 as compared to Rs 243 crore in Q1 FY24. Profit after taxes registered strong growth of 25 per cent to Rs 177 crore in Q1 FY25 vs Rs 142 crores in Q1 FY24.

Join the community of 2M+ industry professionals

Subscribe to our Daily Newsletter

By continuing you agree to our Privacy Policy & Terms & Conditions

Download ETHealthworld App for Realtime updates

Seamless reading experience. Save your favourite.

Scan to download App

Download ETHealthworld App for Realtime updates of content you follow

  • Seamless reading experience
  • Save your favourite articles
Advertisement
Advertisement